Over the past 12 months, 9 insiders at Vera Therapeutics, Inc. filed 24 open-market SEC Form 4 transactions on VERA: 1 purchase worth $250K and 23 sales worth $7.7M. Insiders have been net sellers over this period. The most recent filing was on Jul 7, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 7, 26 | Marshall FordycePRESIDENT AND CEO | SELL | 32.5K | $43.59 | $1.4M |
| Jun 23, 26 | Marshall FordycePRESIDENT AND CEO | SELL | 18.4K | $38.43 | $698K |
| May 12, 26 | Marshall FordycePRESIDENT AND CEO | SELL | 14.2K | $37.09 | $521K |
| Apr 14, 26 | Marshall FordycePRESIDENT AND CEO | SELL | 14.1K | $45.51 | $617K |
| Feb 23, 26 | Robert BrennerChief Medical Officer | SELL | 2.2K | $41.98 | $90K |
| Feb 23, 26 | Marshall FordycePRESIDENT AND CEO | SELL | 16.9K | $41.98 | $711K |
| Feb 23, 26 | Sean GrantCHIEF FINANCIAL OFFICER | SELL | 4.9K | $41.98 | $208K |
| Feb 23, 26 | David Lee JohnsonChief Operating Officer | SELL | 2.6K | $41.98 | $108K |
| Feb 23, 26 | Laurence Matthew SkeltonChief Commercial Officer | SELL | 1.6K | $41.98 | $66K |
| Feb 23, 26 | William D. TurnerChief Regulatory Officer | SELL | 2.2K | $41.98 | $92K |
| Feb 23, 26 | Joseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR | SELL | 3.1K | $41.98 | $131K |
| Dec 15, 25 | William D. TurnerChief Regulatory Officer | SELL | 10.0K | $50.08 | $501K |
| Dec 11, 25 | Patrick G EnrightDirector | BUY | 5.9K | $42.50 | $250K |
| Dec 8, 25 | William D. TurnerChief Regulatory Officer | SELL | 10.0K | $45.31 | $453K |
| Dec 3, 25 | William D. TurnerChief Regulatory Officer | SELL | 10.0K | $40.00 | $400K |
| Nov 21, 25 | Jason S CarterChief Legal Officer | SELL | 3.9K | $27.82 | $107K |
| Nov 11, 25 | Joseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR | SELL | 15.0K | $29.06 | $436K |
| Jun 24, 25 | Patrick G EnrightDirector | BUY | 27.1K | $22.35 | $605K |
| Jun 23, 25 | Patrick G EnrightDirector | BUY | 139.6K | $20.87 | $2.9M |
| Feb 26, 25 | Marshall FordycePRESIDENT AND CEO | SELL | 8.0K | $28.32 | $220K |
| Feb 21, 25 | Marshall FordycePRESIDENT AND CEO | SELL | 10.6K | $27.89 | $296K |
| Jan 8, 25 | Marshall FordycePRESIDENT AND CEO | SELL | 10.0K | $42.03 | $414K |
| Dec 18, 24 | Marshall FordycePRESIDENT AND CEO | SELL | 5.0K | $44.03 | $219K |
| Dec 11, 24 | Marshall FordycePRESIDENT AND CEO | SELL | 14.9K | $47.65 | $700K |
| Nov 25, 24 | Marshall FordycePRESIDENT AND CEO | SELL | 7.7K | $49.00 | $369K |
| Nov 13, 24 | Marshall FordycePRESIDENT AND CEO | SELL | 12.2K | $51.20 | $605K |
| Oct 28, 24 | Beth C SeidenbergDirector | SELL | 14.8K | $49.54 | $710K |
| Oct 23, 24 | Marshall FordycePRESIDENT AND CEO | SELL | 12.7K | $42.00 | $506K |
| Oct 9, 24 | Marshall FordycePRESIDENT AND CEO | SELL | 12.3K | $38.83 | $467K |
| Sep 25, 24 | Marshall FordycePRESIDENT AND CEO | SELL | 8.6K | $47.06 | $393K |
| Sep 19, 24 | Beth C SeidenbergDirector | SELL | 13.8K | $42.31 | $585K |
| Sep 18, 24 | Beth C SeidenbergDirector | SELL | 1.5K | $42.01 | $62K |
| Sep 11, 24 | Marshall FordycePRESIDENT AND CEO | SELL | 9.3K | $37.78 | $346K |
| Aug 28, 24 | Marshall FordycePRESIDENT AND CEO | SELL | 14.9K | $37.53 | $549K |
| Aug 21, 24 | Marshall FordycePRESIDENT AND CEO | SELL | 14.5K | $39.76 | $575K |
| Aug 14, 24 | Marshall FordycePRESIDENT AND CEO | SELL | 15.6K | $37.56 | $587K |
| May 16, 24 | Joseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR | SELL | 18.2K | $43.03 | $766K |
| May 15, 24 | Joseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR | SELL | 8.2K | $42.68 | $347K |
| Apr 10, 24 | Joseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR | SELL | 5.7K | $40.00 | $229K |
| Apr 3, 24 | Sean GrantCHIEF FINANCIAL OFFICER | SELL | 69.8K | $40.06 | $2.8M |
| Mar 25, 24 | Maha KatabiDirector | SELL | 340.0K | $40.50 | $13.8M |
| Mar 22, 24 | Maha KatabiDirector | SELL | 413.4K | $40.51 | $16.7M |
| Mar 21, 24 | Maha KatabiDirector | SELL | 32.8K | $46.18 | $1.4M |
| Jan 30, 24 | Maha KatabiDirector | BUY | 161.3K | $31.00 | $5.0M |
| Jan 10, 24 | Commodore Capital LpTenPercentOwner | SELL | 1.05M | $18.00 | $18.9M |
| Aug 21, 23 | Joanne CurleyChief Development Officer | SELL | 1.5K | $16.66 | $25K |
| Aug 21, 23 | Marshall FordycePresident and CEO | SELL | 5.2K | $16.66 | $87K |
| Aug 21, 23 | Celia LinChief Medical Officer | SELL | 1.5K | $16.65 | $25K |
| Jun 23, 23 | Sean GrantChief Financial Officer | BUY | 5.0K | $16.60 | $83K |
| Jun 20, 23 | Commodore Capital LpTenPercentOwner | BUY | 448.2K | $15.17 | $6.8M |
Over the past 12 months, insiders at Vera Therapeutics, Inc. filed 1 open-market purchase worth $250K and 23 sales worth $7.7M on VERA, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 7, 26.
The largest recent open-market VERA insider purchase in our data was $6.8M by Commodore Capital Lp, TenPercentOwner, filed on Jun 20, 23.
9 different insiders at Vera Therapeutics, Inc. filed open-market SEC Form 4 transactions on VERA over the last 12 months.
InsiderTape plots every VERA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Vera Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →